Clinical Trial

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

Name: Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone — clinical trial record (NCT07314346)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Drug-drug interaction study between Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

Protocol Amendment History 3 changes

notable Primary completion pushed: 2026-06 -> 2026-08 2026-07-17

minor Completion pushed: 2026-06 -> 2026-08 2026-07-17

critical Recruitment opened 2026-04-14

Trial Details

NCT Number	NCT07314346
Lead Sponsor	Atea Pharmaceuticals, Inc.
Conditions	Healthy Volunteer Study
Enrollment	32 participants
Start Date	2025-01-07
Primary Completion	2026-08 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-16